SETL Charts Strong Revenue Growth Amidst Margin Pressure
Standard Engineering Technology Limited (SETL) has announced robust financial results for the third quarter and nine months ended December 31, 2025, showcasing significant top-line expansion driven by strategic initiatives. The company's revenue from operations surged by 36.7% YoY to ₹191.6 crore in Q3FY26, a notable acceleration from ₹140.1 crore in the prior year period. For the nine months ended 9MFY26, revenue grew by 22.4% YoY to ₹547.4 crore.
📉 The Financial Deep Dive
The Numbers:
- Q3FY26 Performance: Total income rose 37.1% YoY to ₹195.9 crore. EBITDA increased 17.0% YoY to ₹33.5 crore, though the EBITDA margin contracted to 17.1% from 20.1% in Q3FY25. Profit Before Tax (PBT) grew 22.7% YoY to ₹26.5 crore, and Net Profit (PAT) recorded a substantial 28.3% YoY increase to ₹20.4 crore. Diluted EPS stood at ₹0.96 compared to ₹0.82 YoY.
- 9MFY26 Performance: Total income was ₹562.2 crore (+23.6% YoY). EBITDA reached ₹102.2 crore (+11.9% YoY), with an EBITDA margin of 18.2% (vs. 20.1% YoY). PBT increased 15.9% YoY to ₹82.7 crore, and PAT grew 18.8% YoY to ₹62.0 crore. Diluted EPS was ₹3.02 (vs. ₹2.71 YoY).
The company's bottom-line growth in PAT, despite margin compression, was supported by improved operational efficiencies and a reduction in interest costs. However, the YoY decline in EBITDA margins (Q3FY26: 17.1% vs 20.1%; 9MFY26: 18.2% vs 20.1%) is a point of concern, primarily attributed by management to an 'unfavourable product mix'. Other income also saw a significant increase of 59.2% YoY in Q3FY26.
🚀 Strategic Analysis & Impact
SETL has undergone a significant strategic transformation, including an official name change to Standard Engineering Technology Limited and a broadening of its business scope. The company is now aggressively targeting high-precision engineering, advanced process technology, and equipment manufacturing across a diverse range of industries, including pharmaceuticals, chemicals, semiconductors, defence, and clean energy segments like hydrogen and solar power.
Inorganic growth has been a key pillar, with SETL acquiring a 51% stake in Scigenesis (India) Pvt. Ltd., adding bioprocess solutions expertise, and Standard C2C Engineering Pvt. Ltd. to bolster in-house multidisciplinary engineering capabilities. An Employee Stock Option Plan (ESOP) has also been implemented to foster talent retention.
🚩 Risks & Outlook
While the revenue momentum and strategic diversification into high-growth sectors like clean energy and semiconductors are positive indicators, the compression in operating margins due to an 'unfavourable product mix' remains a critical risk. Investors will monitor the company's ability to manage its product mix, improve pricing power, and execute its ambitious plans in new technology segments. The balance sheet shows significant growth in assets, with PPE increasing to ₹117.5 crore and ₹35.0 crore in goodwill added from acquisitions. Planned Capex of ₹130 crore over 2-3 years signals future investment, but a lack of explicit Free Cash Flow (FCF) data requires investor scrutiny. Adjusted ROE and ROCE for 9MFY26 (annualised 18.2% and 15.9%) are lower than FY25 levels, suggesting potential dilution in return ratios during this expansion phase. Management's focus on R&D for next-generation products and operational excellence is crucial for navigating these challenges and capitalising on market opportunities.
